Skip to search.
 TSX Down 0.53% TSX Ventures Down 0.63%

ZIOPHARM Oncology, Inc. (ZIOP)

-NasdaqCM
5.49 Down 0.27(4.69%) 4:00PM EDT
|After Hours : 5.65 Up 0.16 (2.91%) 7:31PM EDT - Nasdaq Real Time Price
Prev Close:5.76
Open:5.71
Bid:5.49 x 1000
Ask:5.65 x 300
1y Target Est:21.00
Beta:1.9423
Earnings Date:Oct 31 - Nov 4 (Est.)
Day's Range:5.45 - 5.78
52wk Range:4.45 - 14.93
Volume:1,478,425
Avg Vol (3m):2,155,430
Market Cap:716.42M
P/E (ttm):N/A
EPS (ttm):-1.31
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ZIOPDown 4.69%716.42M
IMGNDown 1.77%241.89M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):100.84
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.34
Quarterly EPS Est (Sep-16) :-0.11
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ZIOPHARM Oncology, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing a portfolio of cancer therapies that address unmet medical needs through synthetic immuno-oncology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback